Prof. Hanoch Senderowitz completed Ph.D. studies in computational organic chemistry at Tel Aviv University in 1993. Between 1993 and 1997,he was a Post Doctorate Fulbright Fellow in the MacroModel development team at Columbia University. In 1997,he returned to Israel and joined the pharmaceutical industry first at Peptor Ltd., where he worked on theoretical and modeling aspects related to the development of peptide-based drugs and latter at EPIX Pharmaceutical, a drug discovery company focused on the development of drugs targeting GPCRs and ion channels, wherehe headed the computational development group and worked on the development of improved tools for modeling the 3D structure of trans-membrane proteins, new QSAR methodologies, new Consensus Scoring algorithms and new methodologies to predict ADME/t properties of potential drugs. Since 2009 he has been a professor at the Department of Chemistry at Bar-Ilan University where he investigated molecular modelling, computer aided drug design and chemo-informatics.